Discovering The Potential Therapeutic Applications of IGHV7-41

Target Name: IGHV7-4-1

NCBI ID: G57289

IGHV7-4-1

Other Name(s): IGHV7-41 | Immunoglobulin heavy variable 7-4-1 | immunoglobulin heavy variable 7-4-1 | IGHV741

Discovering The Potential Therapeutic Applications of IGHV7-41

IGHV7-4-1 (IGHV7-41) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to investigate.

The IGHV7-41 molecule is a member of the IGHV7 family, which is characterized by the presence of a specific domain called the N-terminal alpha-helix. This domain is known to play a crucial role in the stability and stability of the IGHV7 molecules.

One of the unique features of IGHV7-41 is its expression pattern. It is primarily expressed in the brain, where it is found at high levels in various tissues, including the brain cortical regions, spinal cord, and cerebellum. Additionally, it is also expressed in other tissues, including the lungs, heart, liver, and pancreas.

The IGHV7-41 molecule has also been shown to have various functions in different organisms, including its role in the immune system. It has been shown to play a crucial role in the regulation of inflammation and autoimmune diseases.

One of the most promising aspects of IGHV7-41 is its potential as a drug target. Its unique structure and expression pattern make it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its activity.

For example, IGHV7-41 has been shown to play a role in the regulation of pain perception, which makes it an attractive target for pain medications. Additionally, its role in the regulation of inflammation makes it an attractive target for anti-inflammatory drugs.

GHV7-41 has also been shown to play a role in the regulation of cell apoptosis, which is a natural process that helps to remove damaged or dysfunctional cells from the body. This process is important for maintaining tissue homeostasis and has been implicated in various diseases , including cancer.

Furthermore, IGHV7-41 has been shown to play a role in the regulation of stem cell proliferation and differentiation. This process is important for the development and maintenance of tissues and organs, and is crucial for the treatment of diseases that affect these processes, such as cancer.

In conclusion, IGHV7-41 is a non-coding RNA molecule that has a unique structure and expression pattern. Its potential as a drug target and biomarker makes it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its activity . Further research is needed to fully understand its functions and potential therapeutic applications.

Protein Name: Immunoglobulin Heavy Variable 7-4-1

Functions: V region of the variable domain of immunoglobulin heavy chains that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:20176268, PubMed:17576170)

The "IGHV7-4-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV7-4-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets